Thyroid cancer is the most common endocrine cancer, affecting more people each year as detection rates continue to rise.

Maximum-intensity projections (left) and fused transaxial sections (right) of 46-y-old female MTC patient undergoing PET/CT 2 hours after intravenous injection of 193 MBq of [68 Ga]Ga-DOTA-CCK-66.

A newly developed PET imaging agent has been found to be effective in identifying medullary thyroid cancer (MTC) in preclinical and clinical studies, according to research published in the January ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society ...

Liv Hospital integrates PET/CT diagnostics, radionuclide therapies and a multidisciplinary council to create individualized treatment plans for complex cancer and cardiac cases.

The incidence of thyroid cancer in the United States, having plateaued in 2009 after a decades-long increase, has remained stable since then, despite efforts to control an ongoing overdiagnosis of the ...

Papillary thyroid cancer staging depends on age, with stage 2 involving distant spread in younger patients and larger tumors or regional spread in older patients. Diagnosis involves physical exams, ...

Papillary thyroid cancer is widely known as the "good cancer." This term has been around for years and is used ubiquitously. Some think it's "appropriate" because the cancer is highly treatable and ...

Thyroid cancer is often a highly treatable disease. Most cases are detected in early stages and have excellent outcomes. There are several different types of thyroid cancer, and recent changes in ...

Regular monitoring can help identify signs of thyroid cancer recurrence. Many treatment options can help treat recurrent thyroid cancer. The thyroid uses the mineral iodine to produce essential ...